Oxygenators Market By Product Type (Membrane Oxygenators, Bubble Oxygenators, Rotational Oxygenators), By Application (Cardiopulmonary Bypass, Extracorporeal Membrane Oxygenation (ECMO), Respiratory Support), By End-User Industry (Hospitals & Healthcare Facilities, Research Institutions, Medical Device Manufacturers), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Oxygenators Market was valued at USD 2.3 Billion in 2024-e and will surpass USD 3.7 Billion by 2030; growing at a CAGR of 6.9% during 2025-2030.

The oxygenators market is experiencing significant growth, driven by advances in medical technology and the increasing demand for life-saving procedures. Oxygenators are critical devices used to provide oxygenation and remove carbon dioxide from the blood in various medical applications, including cardiopulmonary bypass, ECMO, and respiratory support. These devices play a crucial role in treating patients suffering from severe respiratory failure or during complex heart surgeries. As the healthcare industry continues to evolve, oxygenators are becoming more advanced, enabling medical professionals to perform intricate procedures with greater precision, enhancing patient outcomes.

Membrane Oxygenators Segment Is Largest Owing to Their High Efficiency and Reliability

Membrane oxygenators hold the largest share in the oxygenators market, primarily due to their superior efficiency and reliability. These devices utilize a semi-permeable membrane to facilitate gas exchange, allowing them to provide a more controlled and consistent oxygenation process. Membrane oxygenators are widely used in both cardiopulmonary bypass and ECMO applications, as they are designed to support patients with severe lung and heart conditions. The continuous advancements in membrane technology have significantly improved the oxygenators' performance, making them a preferred choice in critical medical procedures. Furthermore, these devices are highly efficient in oxygenating blood with minimal blood trauma, which is a key factor in their widespread adoption in hospitals and healthcare facilities.

Membrane oxygenators are increasingly favored in hospitals due to their effectiveness in providing long-term respiratory support during critical surgeries. With a focus on reducing complications associated with mechanical oxygenation, these devices contribute to improving the overall survival rate of patients undergoing complex procedures, such as cardiac surgeries. As medical technologies continue to advance, the efficiency of membrane oxygenators is expected to further improve, reinforcing their dominant position in the oxygenators market.

Extracorporeal Membrane Oxygenation (ECMO) Segment Is Fastest Growing Owing to Rising Demand for Critical Care

The ECMO segment is the fastest-growing application for oxygenators, largely driven by the increasing prevalence of respiratory and cardiac diseases that require extracorporeal support. ECMO provides critical care for patients whose heart and lungs are severely damaged or failing. It allows the heart to pump and the lungs to oxygenate the blood while bypassing the heart and lungs themselves. The growing number of patients with chronic lung diseases, heart failure, and the rising demand for emergency respiratory support are driving the adoption of ECMO devices. Furthermore, advancements in ECMO technology, including more portable and user-friendly systems, are making these devices more accessible, thereby contributing to their rapid growth.

The global demand for ECMO is escalating, particularly in developed countries with advanced healthcare infrastructure. Hospitals and specialized care centers are increasingly utilizing ECMO as a last-resort therapy for critically ill patients, which is driving the growth of the oxygenators market. As ECMO procedures continue to evolve, the integration of oxygenators with other medical devices is expected to enhance the overall efficiency of life support systems.

Hospitals & Healthcare Facilities Segment Is Largest End-User Industry Due to High Demand for Critical Care

The hospitals and healthcare facilities segment is the largest end-user industry in the oxygenators market. This can be attributed to the high demand for oxygenators in intensive care units (ICUs), emergency departments, and operating rooms, where patients require respiratory or circulatory support during critical procedures. The increasing incidence of diseases such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and cardiovascular disorders, which often necessitate mechanical ventilation or ECMO, is propelling the demand for oxygenators in hospitals. Moreover, hospitals are equipped with the latest oxygenation technologies to support patients undergoing complex surgeries or those in need of respiratory support during recovery.

Hospitals remain the primary setting for oxygenator applications due to their ability to manage high-risk patients and provide intensive care. This segment benefits from continuous advancements in medical equipment and the integration of oxygenators with advanced life support systems, leading to improved patient outcomes. As healthcare systems worldwide focus on enhancing critical care capabilities, the role of hospitals in driving the growth of the oxygenators market remains pivotal.

North America Is Largest Region Owing to Advanced Healthcare Infrastructure

North America is the largest region in the oxygenators market, accounting for a significant share of the global market. The region benefits from an advanced healthcare infrastructure, widespread adoption of innovative medical technologies, and a high prevalence of cardiovascular and respiratory diseases that require oxygenator devices. The United States, in particular, is a key contributor to this growth, with a large number of hospitals and healthcare facilities utilizing advanced life support systems, including ECMO and cardiopulmonary bypass procedures. Moreover, the increasing number of patients undergoing complex surgeries, such as heart transplants and coronary artery bypass surgeries, is further driving the demand for oxygenators in the region.

In addition to the growing number of critical care patients, North America's strong regulatory framework and the presence of leading medical device manufacturers provide a solid foundation for the expansion of the oxygenators market. With continued advancements in healthcare technology and an aging population, North America is expected to maintain its dominance in the oxygenators market for the foreseeable future.

Competitive Landscape and Leading Companies

The oxygenators market is highly competitive, with several established companies dominating the landscape. Leading companies such as Medtronic, LivaNova, Getinge AB, and Fresenius Medical Care are actively involved in the development and commercialization of advanced oxygenators. These companies invest heavily in research and development to introduce more efficient and durable oxygenation devices. The market is also seeing increased collaboration between oxygenator manufacturers and healthcare providers to improve the clinical outcomes of patients requiring critical care.

The competitive landscape is characterized by the introduction of innovative products, technological advancements, and a strong focus on improving patient safety. With the increasing demand for ECMO procedures and cardiopulmonary support, companies are working towards developing more efficient, portable, and cost-effective oxygenators. Additionally, the market is expected to see an influx of smaller players focusing on niche applications, further intensifying the competition. As the demand for oxygenators continues to grow, both established and emerging companies are likely to play an integral role in shaping the future of the market.

Recent Developments:

• Medtronic announced the launch of a new line of advanced oxygenators designed for enhanced efficiency during cardiopulmonary bypass procedures in early 2024.
• LivaNova has expanded its ECMO product portfolio with the release of a more compact and portable oxygenator for improved patient mobility and ease of use.
• Getinge AB received FDA clearance for its next-generation membrane oxygenator, which incorporates a new coating technology to reduce blood cell damage during ECMO treatments.
• Fresenius Medical Care completed an acquisition of a leading medical device company specializing in respiratory support systems, strengthening its portfolio of oxygenation solutions.
• Terumo Corporation announced a collaboration with leading universities for research into next-generation oxygenators designed to improve efficiency and patient outcomes during critical surgeries.

List of Leading Companies:

• Medtronic
• LivaNova
• Getinge AB
• Terumo Corporation
• Fresenius Medical Care
• Maquet (Part of Getinge Group)
• Sorin Group (Now LivaNova)
• Cytosorbents Corporation
• Nipro Corporation
• Smiths Medical
• Jiangsu Canta Medical Tech Co., Ltd.
• Aquarius Medical Technologies
• Pall Corporation
• ReliantHeart Inc.
• CardioMed Supplies Inc

Report Scope: